Navigation Links
Chopped up proteins trigger autoimmunity
Date:1/24/2008

He has also discovered that PM/Scl-75, one of the components from which the exosome is built, is cut as soon as a cell dies. Finally, Schilders has identified an exosome-associated protein that is also frequently recognised by antibodies. These antibodies possibly form an interesting additional marker for the diagnosis of the PM/Scl overlap syndrome.

In people who suffer from an autoimmune disease, the immune system has been disrupted to such an extent that it produces antibodies against a persons own substances. In polymyositis/sclerodermia (PM/Scl) overlap syndrome these antibodies are targeted at the exosome. This complex of proteins is involved in the degradation of RNA in the cell. RNA forms an essential link in the flow of information in a cell and, therefore, a strict control over the degradation of RNA is vitally important.


'/>"/>

Contact: Dr. G.W. Schilders
g.schilders@ncmls.ru.nl
Netherlands Organization for Scientific Research
Source:Eurekalert

0

GOOD

Page: 1

Related medicine news :

1. The Handbook of Proteins
2. New Proteins That Help HIV Grow Identified
3. Scientists get first look at how water lubricates proteins
4. 2 proteins may be survival markers in some breast cancers
5. Immune Proteins Warn of Early Lung Cancer
6. Loss of gene leads to protein splicing and buildup of toxic proteins in neurons
7. Heat shock proteins are co-opted for cancer
8. Penn study finds pro-death proteins required to regulate healthy immune function
9. Molecule May Trigger Psoriasis
10. Protein power: Researchers trigger insulin production in diabetic mice
11. Scripps research scientists discover chemical triggers for aggression in mice

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...nt to 113 chest X-rays, study finds , , ... of patients who have abdominal/pelvic CT scans re...pose them to extra radiation, U.S. researchers say...eries were performed on 500 patients aged 9 months...ears of age. The researchers concluded that 35.3 p...
(Date:11/30/2009)...unique online and mobile tool empowers patients to...isions ,, ARLINGTON, Va., Nov. 30 /PRNewswir...#1 HIV/AIDS resource online, today launched My Hea...V/AIDS-infected patients the ability to save, trac...d with sponsorship from Merck, is available at ww...
(Date:11/30/2009)...Nov. 30 Tyco Internation...10 annual general meeting of shareholders will be ...tral European time at the Park Hyatt Zurich Hotel,...egistered shareholders as of January 11, 2010 (the...al general meeting. Additionally, individuals who...
(Date:11/30/2009)... and extensive discussion in the scientific commun...ealth Care (IQWiG) presents its methods for evalua...stitute can now apply these methods when working o... Committee (G-BA). The method developed by IQWiG i...KV-Spitzenverband [National Association of Health ...
(Date:11/30/2009)...Newswire/ -- Reportlinker.com announces that a new...gue: ,, Key Players and Innovative Start-Ups i...ts, pharma, food and drinks ,, http://www.rep...Start-Ups-in-Nutraceuticals-Emerging-strategies-in...traceuticals are bioactive compounds with properti...
Breaking Medicine News(10 mins):Health News:CT Scan Patients May Get Unnecessary Imaging 2Health News:TheBody.com Launches My Health Tracker, Enabling HIV-Positive Patients to Track Lab Results, Medications and Supplements 2Health News:IQWiG presents a method for evaluating the relation between cost and benefit 2Health News:IQWiG presents a method for evaluating the relation between cost and benefit 3Health News:IQWiG presents a method for evaluating the relation between cost and benefit 4Health News:IQWiG presents a method for evaluating the relation between cost and benefit 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 3Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 4Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 6
...ver for those who prefer relaxing with a good cup ...ed by researchers from Charite Hospital Universita...European Heart Journal, has come out with a study ...hich protect the heart and have anti-cancer effect...
... in adolescents and young adults was associated wi...heart//, researchers report in Circulation: Journa...udy of American Indians, average age 26.5, those w... ventricular wall thickness, higher left ventricul...
...er week are at greater risk of developing osteoart...ccording to research conducted by the University o...is characterised by joint pain, which can be relie...s arose in the long-distance joggers' knees, said ...
...age healing through mantras! Sanskrit scholars of ...rsity// have initiated a research project, said to...es through Vedic chants. A state-of-the-art a...icipating in the research. The lab would inv...
... is a boon for the kith and kin of those people wh...vaccine is currently available in 33 countries all...rp & Dohme. This vaccine was formed by Professor I...g contender for Nobel Prize. In the middle E...
...California heaved a sigh of relief when the health...tween the meningitis// and the encephalitis cases ... have clearly indicated that the bacteria, which c...erial infection. An elementary school studen...
Other Medicine News:Health News:Hypertension, Prehypertension in Youngsters Linked With Heart Enlargement 2Health News:Hypertension, Prehypertension in Youngsters Linked With Heart Enlargement 3
(Date:11/30/2009)...L, Wash., Nov. 30 SCOLR ...at on November 25, 2009, the NYSE Amex LLC (the "E...d the Company,s plan to comply with its previously...)(iv) of the Exchange Company Guide. Specifically...stained losses which were so substantial in relati...
(Date:11/30/2009)...STON, S.C., Nov. 30 The Eleventh A...", will be held at the Charleston Place Hotel in t...r 3-4, 2009. Dr. Cheryl Liljestrand, Dr. Harry Gu...s with Stipkala LLC, will attend. SEBIO 2009 prom...nvestors, scientists, entrepreneurs, and service p...
(Date:11/30/2009)...W YORK, Nov. 30 Reportlinker.com a...lable in its catalogue: ,, Cardiac Defibrillat..., http://www.reportlinker.com/p0164315/Cardiac-De...ort.html ,, Cardiovascular disease (CVD) is o...den cardiac arrest survivors are prone to arrhythm...
Breaking Medicine Technology:SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 1International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 2International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 3International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 4International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 5International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 6International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 7Sage Software Healthcare Inc Celebrates National Health Center Week 54311 1Sage Software Healthcare Inc Celebrates National Health Center Week 54311 2Cystic Fibrosis Foundation Receives Second 4 Star Rating from Charity Navigator for Exceptional Fiscal Management 54308 1Cystic Fibrosis Foundation Receives Second 4 Star Rating from Charity Navigator for Exceptional Fiscal Management 54308 2
...S WIRE)--Apr 14, 2007 - In a late-breaker,presenta...sociation,for the Study of the Liver (EASL), resea... analysis of the PROVE 1 clinical trial,which is ... with,the investigational hepatitis C protease inh...h pegylated interferon (peg-IFN) and,ribavirin (RB...
...RNewswire-FirstCall/ -- ACCESS,PHARMACEUTICALS, IN...mechanism of ProLindac,s anticancer activity will ... Cancer Research (AACR) 2007,annual meeting in Los... two poster presentations describe preclinical stu...inent institutes in France. , "We are delighted to...
Other Medicine Technology:Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 2Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 3Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 4Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 5Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 6Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 7Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 8Access Pharmaceuticals Announces Poster Presentations on ProLindac,at the American Association for Cancer Research 2007 Annual Meeting 2Access Pharmaceuticals Announces Poster Presentations on ProLindac,at the American Association for Cancer Research 2007 Annual Meeting 3Access Pharmaceuticals Announces Poster Presentations on ProLindac,at the American Association for Cancer Research 2007 Annual Meeting 4
Silicone Wedge (137 Style)
Silicone Tire (281 Style)
Silicone Strip (225 Style)
Silicone Boat (60 Style)
Medicine Products: